Abstract
Background and aim
Our primary objective is to report the results of the ultrasound (US)-guided revision technique of transhepatic shunt in patients in whom intrahepatic portosystemic shunt was created by the percutaneous or conventional route. Our secondary objective is to investigate whether there is an association between the indication for a portosystemic shunt and the need for post-shunt revision.
Methods
Data from 117 consecutive patients who had a transjugular intrahepatic portosystemic shunt placed percutaneously or conventionally were extracted from hospital electronic medical records and examined those who underwent revision within 11 years and those who did not. US-guided transhepatic shunt revision technique was evaluated in terms of technical success, complications, and patency. In addition, the relationship between etiology and the need for revision was also examined using the chi-square test in three groups.
Results
Forty six point two percent of patients who underwent transjugular intrahepatic portosystemic shunt required one or more revisions within 11 years. While patency of the shunt could be established via the transjugular route in 83.3% of revision patients, it was necessary to use the transhepatic route in 16.7%. The technical success rate for the US-guided transhepatic shunt revision method was 100%, and the pressure gradient between the portal and hepatic venous systems decreased below 10 mmHg in all patients at the end of the procedure.
Conclusion
US-guided transhepatic shunt revision is a safe and effective method where transjugular revision cannot be performed. In addition, the revision rate is significantly higher in patients who have undergone transjugular intrahepatic portosystemic shunt due to Budd-Chiari syndrome compared with other groups.
Similar content being viewed by others
Data Availability
Not applicable.
References
Colapinto RF, Stronell RD, Gildiner M et al (1983) Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 140(4):709–714. https://doi.org/10.2214/ajr.140.4.709
Haskal ZJ, Pentecost MJ, Soulen MC et al (1994) Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. AJR Am J Roentgenol 163(2):439–444. https://doi.org/10.2214/ajr.163.2.8037046
LaBerge JM, Somberg KA, Lake JR et al (1995) Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 108(4):1143–1151. https://doi.org/10.1016/0016-5085(95)90213-9
Nazarian GK, Ferral H, Castaneda-Zuniga WR et al (1994) Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology 192(1):231–234. https://doi.org/10.1148/radiology.192.1.8208944
Saxon RS, Ross PL, Mendel-Hartvig J et al (1998) Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 207(3):683–693. https://doi.org/10.1148/radiology.207.3.9609891
Sterling KM, Darcy MD (1997) Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. AJR Am J Roentgenol 168(1):239–244. https://doi.org/10.2214/ajr.168.1.8976952
LaBerge JM, Ferrell LD, Ring EJ et al (1993) Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 4(6):779–786. https://doi.org/10.1016/s1051-0443(93)71972-7
Reuben A (1984) Biliary proteins. Hepatology 4(5 Suppl):46S-50S. https://doi.org/10.1002/hep.1840040808
Ducoin H, El-Khoury J, Rousseau H et al (1997) Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 25(5):1064–1069. https://doi.org/10.1002/hep.510250503
Teng GJ, Bettmann MA, Hoopes PJ et al (1998) Transjugular intrahepatic portosystemic shunt: effect of bile leak on smooth muscle cell proliferation. Radiology 208(3):799–805. https://doi.org/10.1148/radiology.208.3.9722863
Mattsson EJ, Kohler TR, Vergel SM et al (1997) Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 17(10):2245–2249. https://doi.org/10.1161/01.atv.17.10.2245
Haskal ZJ, Cope C (1994) Combined transhepatic and transvenous approach to hepatic vein stenosis after transjugular intrahepatic portosystemic shunt (TIPS). Cardiovasc Intervent Radiol 17(3):173–175. https://doi.org/10.1007/BF00195516
Chen SL, Xiao CJ, Wang S et al (2020) The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction. Gastroenterol Res Pract 9150173. https://doi.org/10.1155/2020/9150173
Boyvat F, Harman A, Ozyer U et al (2008) Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: direct simultaneous puncture of the portal vein and inferior vena cava. AJR Am J Roentgenol 191(2):560–564. https://doi.org/10.2214/AJR.07.3496
Petersen B, Uchida BT, Timmermans H et al (2001) Intravascular US-guided direct intrahepatic portacaval shunt with a PTFE-covered stent-graft: feasibility study in swine and initial clinical results. J Vasc Interv Radiol 12(4):475–486. https://doi.org/10.1016/s1051-0443(07)61887-9
Boyvat F, Aytekin C, Harman A et al (2006) Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: percutaneous ultrasound-guided direct simultaneous puncture of the portal vein and vena cava. Cardiovasc Intervent Radiol 29(5):857–861. https://doi.org/10.1007/s00270-005-0317-4
Mostafa K, Trentmann J, Andersson J et al (2022) Percutaneous creation of direct intrahepatic portosystemic shunts - an alternative for failed TIPS creation. CVIR Endovasc 5(1):16. https://doi.org/10.1186/s42155-022-00292-4
Chan CY, Liang PC (2010) Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach. Korean J Radiol 11(4):469–471. https://doi.org/10.3348/kjr.2010.11.4.469
Miraglia R, Maruzzelli L, Luca A (2013) Recanalization of occlusive transjugular intrahepatic portosystemic shunts inaccessible to the standard transvenous approach. Diagn Interv Radiol 19(1):61–65. https://doi.org/10.4261/1305-3825.DIR.5541-12.1
Spiliopoulos S, Vasiniotis Kamarinos N, Konstantos C et al (2018) Recanalization of Occluded Transjugular Intrahepatic Portosystemic Shunts Using the Rosch-Uchida Stiffening Cannula. Cardiovasc Intervent Radiol 41(5):799–803. https://doi.org/10.1007/s00270-018-1887-2
Tuite DJ, Rehman J, Davies MH et al (2007) Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis. J Vasc Interv Radiol 18(12):1571–1575. https://doi.org/10.1016/j.jvir.2007.08.009
Qi X, Yang M, Fan D et al (2013) Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 48(7):771–784. https://doi.org/10.3109/00365521.2013.777775
Ferral H, Banks B, Wholey M et al (1998) Techniques for transjugular intrahepatic portosystemic shunt revision. AJR Am J Roentgenol 171(4):1041–1047. https://doi.org/10.2214/ajr.171.4.9762993
Tanaka T, Gunther RW, Isfort P et al (2011) Pull-through technique for recanalization of occluded portosystemic shunts (TIPS): technical note and review of the literature. Cardiovasc Intervent Radiol 34(2):406–412. https://doi.org/10.1007/s00270-010-9874-2
Acknowledgements
No one other than the authors of this article contributed to this study.
Author information
Authors and Affiliations
Contributions
Özgür Özen, MD - Conceptualization; Data curation; Formal analysis. Fatih Boyvat, MD - Supervision; Validation; Visualization. Çağrı Kesim, MD - Project Administration, Writing - original draft; Writing - review & editing. Tolga Zeydanlı, MD - Resources; Software. Pelin Kaya, MD - Investigation; Methodology.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This study was approved by Başkent University Institutional Review Board (Project no: KA23/21).
Informed consent
This study has obtained IRB approval from Başkent University, and the need for informed consent was waived.
Consent for publication
For this type of study, consent for publication is not required.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• If the transjugular approach fails, the transhepatic approach is useable.
• Percutaneous TIPS revisions can be performed safer under ultrasound guidance.
• The ultrasound-guided puncture for TIPS revisions were technically 100% successful.
• No complications occurred during any of the operations.
• The need for revision is higher in the Budd-Chiari patient group than in others.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Özen, Ö., Boyvat, F., Kesim, Ç. et al. Percutaneous revision of dysfunctional shunts in patients who underwent intrahepatic portosystemic shunt procedure via percutaneous or conventional method: 11-years single center experience. Ir J Med Sci 192, 2755–2761 (2023). https://doi.org/10.1007/s11845-023-03390-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-023-03390-x